Momenta (MNTA) Crushed as Amphastar Wins Appeals Court Stay in Generic LOVENOX Case
Tweet
Share
E-mail
Get Alerts MNTA Hot Sheet
Join SI Premium – FREE
Momenta Pharmaceuticals Inc. (Nasdaq: MNTA) is getting crushed Thursday, down about 17 percent early in the session.
Shares are moving on the news that Amphastar won appeals court stay in generic LOVENOX case. LOVENOX is made by Watson Pharma (NYSE: WPI). Watson and Amphastar argued LOVENOX appeal on January 24th.
Shares are moving on the news that Amphastar won appeals court stay in generic LOVENOX case. LOVENOX is made by Watson Pharma (NYSE: WPI). Watson and Amphastar argued LOVENOX appeal on January 24th.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- Autodesk says it will not submit 10-K report within 15-day grace period, shares down
- Elevance Health (ELV) hikes 2024 earnings outlook, shares climb
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Litigation, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
